Phase I study of gemcitabine (GEM) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Kawabata, S [1 ]
Oka, M [1 ]
Fukuda, M [1 ]
Kinoshita, A [1 ]
Fukuda, M [1 ]
Nagashima, S [1 ]
Nakamura, Y [1 ]
Nakano, H [1 ]
Soda, H [1 ]
Kohno, S [1 ]
机构：
[1] Nagasaki Univ, Nagasaki 852, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7291
引用
收藏
页码：688S / 688S
页数：1
相关论文
共 50 条
  • [1] Combination chemotherapy with carboplatin(CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Batzios, S
    Karvounis, N
    Athanassiou, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S263
  • [2] Ifosfamide (IFX), Mesna (M), Carboplatin (CBDCA) and Gemcitabine (GEM) in advanced/metastatic non small cell lung cancer (NSCLC)
    Puerto, JM
    Lomas, M
    Inoriza, A
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [3] A phase I study of bortezomib, paclitaxel, carboplatin (CBDCA), and radiotherapy (RT) for locally advanced non-small cell lung cancer (NSCLC)
    Schild, S. E.
    Molina, J. R.
    Dy, G. K.
    Rowland, K. M.
    Sarkaria, J. N.
    Thomas, S. P.
    Northfelt, D. W.
    Kugler, J. W.
    Foster, N. R.
    Adjei, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase I study of gemcitabine and carboplatin in non-small cell lung cancer
    Carmichael, J
    Allerheiligen, S
    Walling, J
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 55 - 59
  • [5] Phase II study of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)
    Firvida, JL
    Rodriguez, R
    Sabin, P
    Castellanos, J
    Mata, JG
    Salgado, M
    Vazquez, S
    Lazaro, M
    Delgado, FM
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [6] A phase I study of biweekly combination chemotherapy with gemcitabine (GEM) and carboplatin (CBDCA) for inoperable stages IIIB and IV non-small-cell lung cancer (NSCLC).
    Hasegawa, Y
    Takanashi, S
    Nakagawa, H
    Okudera, K
    Kumagai, M
    Hayashi, A
    Morimoto, T
    Taima, K
    Okumura, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 675S - 675S
  • [7] Gemcitabine (GEM) and carboplatin (CBDCA) combination as first line treatment in non-small cell lung cancer.
    Alberola, V
    Carralo, A
    Massuti, B
    Juan, O
    Sánchez, JJ
    Gómez, JG
    Fernández, ND
    Meana, A
    Rodríguez-Lescure, A
    González, ML
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S66 - S66
  • [8] PHASE I/II STUDY OF S-1 PLUS CARBOPLATIN (CBDCA) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Tamura, K.
    Okamoto, I.
    Ozaki, T.
    Kashii, T.
    Takeda, K.
    Kobayashi, M.
    Matsui, K.
    Shibata, T.
    Nakagawa, K.
    Fukuoka, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 108 - 108
  • [9] Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma
    Gajra, A
    Mehdi, SA
    Kirshner, J
    Newman, N
    Graziano, SL
    LUNG CANCER, 2001, 32 (02) : 189 - 196
  • [10] Phase I trial of gemcitabine (GEM) and cisplatin (CP) for non-small cell lung cancer (NSCLC)
    Shepherd, F
    Cormier, Y
    Burges, R
    Crump, M
    Strack, T
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1080 - 1080
12345